Spironolactone in addition to ACE inhibition to reduce proteinuria in patients with chronic renal disease.

被引：204

作者：

Chrysostomou, A ^{[1
]}

Becker, G ^{[1
]}

机构：

[1] Royal Melbourne Hosp, Parkville, Vic 3052, Australia

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2001年 / 345卷 / 12期

关键词：

D O I：

10.1056/NEJM200109203451215

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：925 / 926

页数：2

相关论文

共 5 条

[1] Role of aldosterone in the remnant kidney model in the rat [J].

Greene, EL ;

Kren, S ;

Hostetter, TH .

JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (04) :1063-1068

[2] ESCAPE OF ALDOSTERONE PRODUCTION IN PATIENTS WITH LEFT-VENTRICULAR DYSFUNCTION TREATED WITH AN ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR - IMPLICATIONS FOR THERAPY [J].

PITT, B .

CARDIOVASCULAR DRUGS AND THERAPY, 1995, 9 (01) :145-149

[3] The effect of spironolactone on morbidity and mortality in patients with severe heart failure [J].

Pitt, B ;

Zannad, F ;

Remme, WJ ;

Cody, R ;

Castaigne, A ;

Perez, A ;

Palensky, J ;

Wittes, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (10) :709-717

[4] ADRENALECTOMY AMELIORATES ABLATIVE NEPHROPATHY IN THE RAT INDEPENDENTLY OF CORTICOSTERONE MAINTENANCE LEVEL [J].

QUAN, ZY ;

WALSER, M ;

HILL, GS .

KIDNEY INTERNATIONAL, 1992, 41 (02) :326-333

[5] Renoprotective benefits of RAS inhibition: From ACEI to angiotensin II antagonists [J].

Taal, MW ;

Brenner, BM .

KIDNEY INTERNATIONAL, 2000, 57 (05) :1803-1817